Peptonic Medical announces a partly underwritten rights issue of 12.5 MSEK
Stockholm, April 10th, 2018 - The Board of Peptonic Medical AB (publ) (’Peptonic’ or ’Company’) today announced a rights issue of 12.5 MSEK with pre-emptive rights for existing shareholders. The issue is underwritten by shareholders and external guarantors to 9,4 MSEK (75%). Issue price is 0,29 SEK per share, which values the company at 12,5 MSEK. Last day of trading including pre-emptive rights is April 13, 2018. Subscription period is April 19 – May 4, 2018. For further details please refer to the company’s webpage or to your investment bank. The stock is listed on